nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR2A—arteriole—focal segmental glomerulosclerosis	0.123	0.418	CbGeAlD
Methysergide—HTR7—endothelium—focal segmental glomerulosclerosis	0.0405	0.137	CbGeAlD
Methysergide—HTR2A—endothelium—focal segmental glomerulosclerosis	0.0253	0.0857	CbGeAlD
Methysergide—SIGMAR1—nephron tubule—focal segmental glomerulosclerosis	0.0217	0.0737	CbGeAlD
Methysergide—HTR1D—kidney—focal segmental glomerulosclerosis	0.0205	0.0694	CbGeAlD
Methysergide—SIGMAR1—cortex of kidney—focal segmental glomerulosclerosis	0.0186	0.0631	CbGeAlD
Methysergide—HTR2B—cortex of kidney—focal segmental glomerulosclerosis	0.0185	0.0629	CbGeAlD
Methysergide—HTR7—kidney—focal segmental glomerulosclerosis	0.0163	0.0553	CbGeAlD
Methysergide—HTR2A—kidney—focal segmental glomerulosclerosis	0.0102	0.0345	CbGeAlD
Methysergide—HTR6—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00134	0.0019	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00134	0.0019	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00133	0.00188	CbGpPWpGaD
Methysergide—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00132	0.00187	CbGpPWpGaD
Methysergide—HTR1B—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00132	0.00187	CbGpPWpGaD
Methysergide—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00131	0.00186	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.0013	0.00185	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.0013	0.00184	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.0013	0.00184	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00129	0.00183	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00129	0.00183	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00129	0.00183	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00129	0.00182	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00128	0.00182	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00128	0.00182	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00128	0.00181	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00126	0.00178	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00125	0.00177	CbGpPWpGaD
Methysergide—HTR2B—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00124	0.00176	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00123	0.00175	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00123	0.00174	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00123	0.00174	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00123	0.00174	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00122	0.00173	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00122	0.00173	CbGpPWpGaD
Methysergide—HTR1A—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00121	0.00172	CbGpPWpGaD
Methysergide—HTR2C—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.0012	0.00171	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.0012	0.00169	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00119	0.00169	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00119	0.00169	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00119	0.00169	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00119	0.00168	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00118	0.00168	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00118	0.00167	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00118	0.00167	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00117	0.00166	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00116	0.00164	CbGpPWpGaD
Methysergide—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00114	0.00161	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00112	0.00159	CbGpPWpGaD
Methysergide—HTR1E—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00112	0.00159	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00112	0.00159	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00111	0.00158	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00109	0.00154	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00109	0.00154	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00109	0.00154	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00108	0.00153	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00108	0.00153	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00108	0.00153	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00108	0.00153	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00107	0.00152	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00106	0.0015	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00105	0.0015	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00105	0.00149	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00105	0.00149	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00105	0.00149	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00104	0.00148	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00104	0.00148	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00104	0.00147	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00104	0.00147	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00103	0.00146	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00102	0.00144	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00101	0.00143	CbGpPWpGaD
Methysergide—HTR1A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.001	0.00142	CbGpPWpGaD
Methysergide—HTR2C—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000999	0.00142	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000994	0.00141	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000991	0.00141	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000991	0.0014	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000989	0.0014	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000988	0.0014	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000987	0.0014	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000986	0.0014	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000982	0.00139	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000961	0.00136	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000958	0.00136	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000953	0.00135	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000952	0.00135	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000949	0.00135	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000947	0.00134	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000935	0.00133	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000923	0.00131	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000922	0.00131	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000916	0.0013	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000911	0.00129	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00091	0.00129	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000907	0.00129	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000906	0.00128	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000906	0.00128	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000903	0.00128	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000897	0.00127	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000882	0.00125	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000877	0.00124	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000867	0.00123	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000856	0.00121	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000855	0.00121	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000843	0.0012	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000839	0.00119	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000838	0.00119	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000832	0.00118	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000827	0.00117	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000823	0.00117	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000815	0.00116	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000806	0.00114	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000802	0.00114	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000801	0.00114	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000796	0.00113	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000787	0.00112	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000769	0.00109	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000769	0.00109	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000766	0.00109	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000766	0.00109	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000765	0.00109	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000765	0.00109	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000764	0.00108	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000763	0.00108	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000762	0.00108	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000761	0.00108	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00076	0.00108	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000759	0.00108	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000758	0.00108	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000754	0.00107	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000746	0.00106	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000745	0.00106	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000743	0.00105	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000738	0.00105	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000732	0.00104	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000728	0.00103	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000725	0.00103	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000706	0.001	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000704	0.000998	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.0007	0.000992	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000698	0.000989	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000697	0.000988	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000696	0.000987	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000695	0.000986	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000694	0.000983	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000692	0.000981	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000691	0.000979	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000684	0.000969	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00068	0.000964	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000676	0.000959	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000666	0.000945	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000665	0.000942	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000639	0.000906	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000638	0.000905	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000638	0.000905	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000635	0.000901	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000634	0.000899	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000633	0.000897	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000621	0.00088	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000621	0.00088	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000618	0.000876	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000602	0.000853	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000591	0.000837	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00059	0.000836	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000584	0.000828	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000584	0.000828	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000583	0.000827	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00058	0.000822	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000568	0.000805	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000567	0.000804	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000566	0.000802	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000564	0.0008	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000563	0.000798	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000562	0.000798	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00056	0.000793	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000556	0.000789	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000536	0.00076	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000533	0.000756	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000515	0.000731	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000513	0.000727	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000495	0.000702	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000495	0.000702	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000492	0.000697	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000491	0.000696	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00049	0.000695	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000489	0.000693	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000486	0.000689	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000481	0.000683	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000481	0.000681	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00048	0.000681	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000477	0.000676	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000473	0.000671	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00047	0.000667	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000467	0.000662	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000463	0.000656	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000455	0.000645	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000455	0.000645	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000452	0.000641	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000452	0.000641	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000445	0.000631	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000442	0.000627	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000439	0.000622	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000433	0.000613	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00043	0.00061	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000416	0.000589	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000411	0.000583	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000411	0.000582	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000409	0.000579	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000408	0.000579	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.0004	0.000567	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00038	0.000539	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00038	0.000538	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000377	0.000535	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000376	0.000533	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000375	0.000532	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000374	0.00053	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000369	0.000523	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000367	0.00052	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000365	0.000517	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000356	0.000504	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000354	0.000503	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000354	0.000502	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000347	0.000492	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000337	0.000478	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000335	0.000475	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000317	0.000449	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000316	0.000448	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000316	0.000448	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000314	0.000445	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.00031	0.000439	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000307	0.000436	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000307	0.000436	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000304	0.000432	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000303	0.000429	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000292	0.000414	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000291	0.000413	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000289	0.000409	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000281	0.000399	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00028	0.000397	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000263	0.000373	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000243	0.000344	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000242	0.000343	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000242	0.000343	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.00024	0.000341	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000235	0.000334	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000234	0.000332	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000233	0.00033	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000221	0.000313	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000202	0.000287	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.0002	0.000283	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000199	0.000283	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000198	0.000281	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000194	0.000275	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000182	0.000258	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000179	0.000254	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000178	0.000253	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000155	0.00022	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000148	0.000209	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000147	0.000208	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000128	0.000181	CbGpPWpGaD
